Treatment of Adriamycin, a type of chemotherapy, may be linked with breast cancer in Hodgkin lymphoma survivors, a study showed. Survivors of Hodgkin lymphoma who have received Adriamycin (doxorubicin ...

After the publication of the 10-year survival data from Milan on the adjuvant use of the block sequential regimen consisting of four cycles of adriamycin followed by eight cycles of intravenous CMF, ...

The combination of doxorubicin and trabectedin (Yondelis) continued to show encouraging activity as first-line treatment of patients with metastatic or unresectable leiomyosarcoma (LMS), according to ...

Doxorubicin (Adriamycin (50 mg)) is a cytotoxic anthracycline antibiotic, prescribed for treating various types of cancer.It works by killing cancer cells. The information provided on this page is ...

Effect of circulating tumor cells distribution in treatment naive and treated patients with advance stage breast cancer on disease burden. Amelioration of acute radiation dermatitis in patients with ...

Micro-organospheres: An automated patient-derived model platform for rapid drug screening of breast cancer. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not ...

This trial looked at a combination of bortezomib, adriamycin and dexamethasone (PAD) for myeloma. It was for people who had not had any other treatment for their myeloma. The trial was open for people ...